Nephros Inc. (NEPH) — 分析摘要
Nephros Inc.(NEPH)的市值为38.98百万美元,最近一年的营收同比增长了+32.7%。净利润率为6.4%。当前市盈率为50.2倍。
核心要点
- 营收同比变化+32.7%
- 净利润率6.4%
- 市盈率50.2倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,NEPH的营收增长为+32.7%,市盈率为50.2倍。
Nephros Inc. (NEPH)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号,应与估值结果一并解读。
自由现金流由上一期为正转为负。
经营现金流为负,但净利润仍为正。
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
36
总部
SOUTH ORANGE, NJ
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。